[HTML][HTML] Importance of drug pharmacokinetics at the site of action

ML Rizk, L Zou, RM Savic… - Clinical and translational …, 2017 - ncbi.nlm.nih.gov
BACKGROUND Due to difficulty in accessing relevant tissues or biological fluids to measure
drug levels, plasma drug concentrations are often collected with the hope that they will …

Imaging of anticancer drug action in single cells

MA Miller, R Weissleder - Nature Reviews Cancer, 2017 - nature.com
Imaging is widely used in anticancer drug development, typically for whole-body tracking of
labelled drugs to different organs or to assess drug efficacy through volumetric …

Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models

I Nessler, E Khera, S Vance, A Kopp, Q Qiu, TA Keating… - Cancer research, 2020 - AACR
Targeted delivery of chemotherapeutics aims to increase efficacy and lower toxicity by
concentrating drugs at the site-of-action, a method embodied by the seven current FDA …

Improved tumor penetration and single-cell targeting of antibody–drug conjugates increases anticancer efficacy and host survival

C Cilliers, B Menezes, I Nessler, J Linderman… - Cancer research, 2018 - AACR
Current antibody–drug conjugates (ADC) have made advances in engineering the antibody,
linker, conjugation site, small-molecule payload, and drug-to-antibody ratio (DAR). However …

Multiscale modeling of antibody-drug conjugates: connecting tissue and cellular distribution to whole animal pharmacokinetics and potential implications for efficacy

C Cilliers, H Guo, J Liao, N Christodolu, GM Thurber - The AAPS journal, 2016 - Springer
Antibody-drug conjugates exhibit complex pharmacokinetics due to their combination of
macromolecular and small molecule properties. These issues range from systemic …

Tracking antibody distribution with near-infrared fluorescent dyes: impact of dye structure and degree of labeling on plasma clearance

C Cilliers, I Nessler, N Christodolu… - Molecular …, 2017 - ACS Publications
Monoclonal antibodies labeled with near-infrared (NIR) fluorophores have potential use in
disease detection, intraoperative imaging, and pharmacokinetic characterization of …

Cellular-resolution imaging of bystander payload tissue penetration from antibody-drug conjugates

E Khera, S Dong, H Huang, L de Bever… - Molecular cancer …, 2022 - AACR
After several notable clinical failures in early generations, antibody–drug conjugates (ADC)
have made significant gains with seven new FDA approvals within the last 3 years. These …

Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy

JF Ponte, L Lanieri, E Khera, R Laleau, O Ab… - Molecular cancer …, 2021 - AACR
Several antibody–drug conjugates (ADC) showing strong clinical responses in solid tumors
target high expression antigens (HER2, TROP2, Nectin-4, and folate receptor alpha/FRα) …

Impact of synthesis methods on the functionality of antibody-conjugated gold nanoparticles for targeted therapy

A Anaki, C Tzror-Azankot, M Motiei, T Sadan… - Nanoscale …, 2024 - pubs.rsc.org
Gold nanoparticles (GNPs) are emerging as promising modular platforms for antibody-
based cancer therapeutics. Their unique physiochemical properties enable efficient binding …

Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy

C Kang, P Han, JS Lee, D Lee, D Kim - Bioconjugate Chemistry, 2020 - ACS Publications
Exosomes have been widely demonstrated as an effective anticancer therapeutic moiety.
However, their clinical translation has been limited by the requirement of prohibitively high …